The Roles of Tissue Factor in Malignant Gliomas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00201903

Enrollment

Registered

2005-09-20

Start date

2004-01-31

Completion date

2006-10-31

Last updated

2017-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumors, Venous Thromboembolism

Keywords

venous thromboembolism, brain tumours, glioma, tissue factor, blood coagulation, tumour progression, low molecular weight heparin

Brief summary

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Detailed description

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* participation in PRODIGE * adult patients * newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas * undergone craniotomy or stereotactic biopsy \> 2 days and \< 4 weeks before

Exclusion criteria

* have known hereditary thrombophilia * are receiving experimental antiangiogenic therapy

Countries

Canada, United States

Outcome results